Healthcare companies are circling around the $7 billion market for injectable drugs that are widely used by hospitals to treat conditions from cancer to pain—but which have often been in short supply.
Drug makers' rising interest in injectables could ease shortages
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content